Daratumumab was granted breakthrough therapy drug status in 2013, for multiple myeloma. It was granted orphan drug status for multiple myeloma, diffuse large B cell lymphoma, follicular …

Oct 14, 2024 · Daratumumab ( Darzalex) is used to treat multiple myeloma to help slow or stop cancer from progressing. Daratumumab is a targeted cancer medicine that binds to a protein …

This page contains brief information about daratumumab and a collection of links to more information about the use of this drug, research results, and ongoing clinical trials.

Aug 1, 2025 · Daratumumab injection is used alone or together with other medicines to treat multiple myeloma (a type of bone marrow cancer).

Daratumumab Injection: learn about side effects, dosage, special precautions, and more on MedlinePlus

On November 21, 2016, the U.S. Food and Drug Administration approved daratumumab (DARZALEX, Janssen Biotech, Inc.) in combination with lenalidomide and dexamethasone, or …

Dec 9, 2024 · Daratumumab, an anti-CD38 monoclonal antibody, has been approved for the treatment of multiple myeloma. Data are needed regarding the use of daratumumab for high …

Study design Daratumumab as a treatment for adult ITP (the DART Study) was an investigator-initiated, multicenter, open-label, phase 2 study of subcutaneous daratumumab in patients with …

What is DARZALEX FASPRO ® (daratumumab and hyaluronidase-fihj)? DARZALEX FASPRO ® is a prescription medicine used alone to treat adults with high-risk smoldering multiple …

Jan 25, 2025 · Darzalex® (daratumumab) is a laboratory-made monoclonal antibody designed to function like a naturally occurring antibody. It targets a specific single protein on the surface of …